Artículos relacionados a Tumors of the Central Nervous System, Volume 2: Gliomas:...
hard to find
"Sinopsis" puede pertenecer a otra edición de este libro.
Reseña del editor:
Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained.
"Sobre este título" puede pertenecer a otra edición de este libro.
- EditorialSpringer
- Año de publicación2011
- ISBN 10 9400706170
- ISBN 13 9789400706170
- EncuadernaciónTapa dura
- Número de páginas458
- EditorHayat M.A.
Comprar nuevo
Ver este artículo
EUR 180,07
Gastos de envío:
EUR 48,99
De Alemania a Estados Unidos de America
Los mejores resultados en AbeBooks
Imagen del vendedor
Tumors of the Central Nervous System, Volume 2
Publicado por
Springer Netherlands
(2011)
ISBN 10: 9400706170
ISBN 13: 9789400706170
Nuevo
Tapa dura
Cantidad disponible: > 20
Librería:
Valoración
Descripción Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. 1. Targeted therapy determined by molecular genetics is emphasized. 2.Several imaging techniques for diagnosis and treatment assessment are detailed. 3.Present and future therapeutic drugs against malignant gliomas are described. 4.The anti-tumor action of . Nº de ref. del artículo: 5825375
Comprar nuevo
EUR 180,07
Convertir moneda
Gastos de envío:
EUR 48,99
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío
Imagen del vendedor
Tumors of the Central Nervous System, Volume 2
Publicado por
Springer Netherlands Apr 2011
(2011)
ISBN 10: 9400706170
ISBN 13: 9789400706170
Nuevo
Tapa dura
Cantidad disponible: 2
Librería:
Valoración
Descripción Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained. 480 pp. Englisch. Nº de ref. del artículo: 9789400706170
Comprar nuevo
EUR 213,99
Convertir moneda
Gastos de envío:
EUR 23,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío
Imagen del vendedor
Tumors of the Central Nervous System, Volume 2 : Gliomas: Glioblastoma (Part 2)
Publicado por
Springer Netherlands
(2011)
ISBN 10: 9400706170
ISBN 13: 9789400706170
Nuevo
Tapa dura
Cantidad disponible: 1
Librería:
Valoración
Descripción Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained. Nº de ref. del artículo: 9789400706170
Comprar nuevo
EUR 217,79
Convertir moneda
Gastos de envío:
EUR 32,99
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío